Pulmonary Rehabilitation in End-Stage Liver Disease

Status Recruiting

Clinical Trial Summary

The purpose of this study is to assess the impact of exercise on sarcopenia and frailty. The exercise that will be performed in this study will include either pulmonary rehabilitation or a formal home based video strengthening program

Clinical Trial Description

Participants will be randomized into two groups. The Pulmonary Rehabilitation group will undergo exercise under a supervised setting for a total duration of 12 weeks. Patients will perform endurance (treadmill or cycle ergometer), strength (weight resistance) and flexibility training twice a week for a period of an hour per session. Exercises will be supervised by physiotherapists or exercise physiologists. Compliance and performance will be monitored by the trainer. They will receive a pedometer for home use. The Home based program group will perform REST for 10 minutes daily, increasing to 20 minutes daily, after the second week, in their home environment. The total duration of the intervention will be 12 weeks. Patients will be provided with pedometers, REST video and binder, with instructions on how to perform exercises, and resistance bands. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03266575
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Recruiting
Phase	N/A
Start date	February 1, 2018
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03557086` - A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease	N/A
Completed	`NCT04604860` - Use of EL-FIT App to Promote Physical Activity	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Recruiting	`NCT01728688` - Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis	Phase 1/Phase 2
Recruiting	`NCT01724697` - Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis	Phase 1/Phase 2
Recruiting	`NCT01728727` - Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis	Phase 1/Phase 2
Not yet recruiting	`NCT01412593` - Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis	Phase 1/Phase 2
Completed	`NCT00374582` - End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)	N/A
Completed	`NCT00249652` - Transplant and Addiction Project (TAP) - 1	Phase 1/Phase 2
Recruiting	`NCT05998330` - LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease	N/A
Completed	`NCT04546048` - The Early Strength Training Program in Post-transplant Liver Cases	N/A
Active, not recruiting	`NCT03580629` - Pilot Study of the Liver Live Donor Champion Program	N/A
Recruiting	`NCT04037995` - Real World Study of End-stage Liver Disease in China
Recruiting	`NCT03870568` - Functional Assessment in Liver Transplantation
Recruiting	`NCT03633812` - Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver Transplantation
Active, not recruiting	`NCT02889094` - French HIV-HBV Cohort
Completed	`NCT02444273` - The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital	N/A
Recruiting	`NCT01711073` - Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease	Phase 1
Not yet recruiting	`NCT06069050` - SALT in Adolescents With End-stage Liver Disease	N/A
Recruiting	`NCT03228290` - Functional Assessment in Liver Transplantation